Search filters

List of works by Juan A. Pineda

A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.

scientific article published on 24 September 2013

A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection

article

A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)

scientific article published on 10 July 2019

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

scientific article published on 12 December 2012

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

scientific article published on 16 October 2013

A review of current anti-HCV treatment regimens and possible future strategies

article

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

scientific article published in April 2010

Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain

scientific article published in September 1991

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

scientific article published on 29 November 2014

Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C.

scientific article published in August 2005

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

scientific article published on 01 October 2008

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

scientific article published in March 2011

Association between hepatitis C virus seroreactivity and HIV infection in non-intravenous drug abusing prostitutes

scientific article published on May 1995

Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4.

scientific article published on 11 October 2011

Association of BST-2 Gene Variants With HIV Disease Progression Underscores the Role of BST-2 in HIV Type 1 Infection ⬇️

scientific article published on November 12, 2012

Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

scientific article published on 8 January 2015

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load

scientific article published on 31 October 2013

Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.

scientific article published in January 2014

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries

scientific article published on 4 December 2017

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

scientific article published on 7 August 2017

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

scientific article published in Scientific Reports

Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV.

scientific article published on 14 October 2012

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.

scientific article published on May 2008

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

scientific article published on 19 February 2013

Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy

scientific article published on 01 November 2004

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

scientific article

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

scientific article published on November 2016

Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient

scientific article published in July 2003

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

scientific article published on September 2017

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients

scientific article

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

scientific article published on 22 July 2010

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort

scientific article

Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.

scientific article published on 10 April 2013

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.

scientific article published in September 2007

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

scientific article published on 13 August 2012

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients

scientific article published in January 2011

Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users.

scientific article

Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection

scientific article

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

scientific article published on 23 July 2016

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

scientific article published on 19 May 2017

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

scientific article published in May 2009

Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain.

scientific article published on 3 November 2014

Diagnosis of infections with Leishmania infantum using PCR-ELISA

scientific article published on 01 June 2001

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients

scientific article

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

scientific article published on June 2012

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

scientific article published on 6 March 2011

Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

article

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

scientific article published in March 2004

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

scientific article published on 29 May 2013

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

scientific article published on 16 February 2017

Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.

scientific article published on 24 February 2014

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

scientific article published in October 2009

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

scientific article published on 27 June 2018

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

scientific article

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment

scientific article published on 6 October 2011

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

scientific article published on 21 June 2008

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

scientific article published on 13 October 2008

Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection.

scientific article

Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus

scientific article

Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain.

scientific article published in May 2001

Evolutionary analysis identifies an MX2 haplotype associated with natural resistance to HIV-1 infection.

scientific article published on 14 June 2014

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

scientific article published on 28 June 2014

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

article

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

article

Failure to detect silent HIV infection by polymerase chain reaction in subjects at risk for heterosexually transmitted HIV type 1 infection

scientific article published on 01 September 1993

False-positive results of leishmanin skin test due to phenol-containing diluent

scientific article

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

scientific article published on October 2009

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

scientific article published on 24 January 2017

Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability

scientific article published on 16 May 2019

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

scientific article published on 21 June 2019

Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection

article

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

article

HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

article

HCV epidemiology in high-risk groups and the risk of reinfection.

scientific article

HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients.

scientific article

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

scientific article published in April 2005

HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals

scientific article published on 01 June 2019

HIV-1 progression in hepatitis-C-infected drug users

scientific article published on 01 April 2001

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

scientific article published on May 2017

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

scientific article published on 29 June 2012

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.

scientific article published on January 2014

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

scientific article published on 31 May 2016

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

scientific article

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

scientific article

Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

scientific article published on March 2015

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.

scientific article published on 25 November 2011

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

scientific article published on 24 October 2008

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

scientific article published on 11 September 2012

Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity

scientific article published in March 1993

Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves

scientific article published on 16 July 2013

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

scientific article published on August 2012

Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases

scientific article published in November 1993

Hepatitis C virus infection in Spain: Challenges in the track to elimination

scientific article published on 14 February 2019

Hepatitis C virus infection in sexually promiscuous groups

scientific article published on August 1990

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

scientific article published on 23 July 2015

Hepatitis aguda C en varones homosexuales infectados por VIH: ¿una segunda oleada de coinfección por VIH y VHC?

scientific article published on 27 November 2014

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

article

High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.

scientific article

High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients

scientific article published on 5 November 2014

High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease

scientific article published on December 2014

High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack

scientific article published in July 2008

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks

scientific article published on 14 May 2019

Host genetics.

scientific article

IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.

scientific article published on September 2015

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians

scientific article

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

scientific article published on 9 July 2015

Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection

scientific article

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

scientific article published in May 2011

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

scientific article published on 27 September 2011

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

scientific article published on September 2015

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

scientific article published on 25 October 2011

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

scientific article published on 28 January 2018

Impact of observer experience on the reproducibility of transient elastometry in HIV/HCV co-infected patients.

scientific article published on July 2009

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus

scientific article published on 23 October 2003

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients

scientific article published on August 2014

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.

scientific article published in December 2006

Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C

scientific article published on 23 May 2006

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

scientific article

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection

scientific article

Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain

article

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

scientific article published on 05 September 2012

Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study

scientific article published on 18 December 2018

Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients

scientific article (publication date: 2012)

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

scientific article published on 14 October 2007

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

scientific article published on 6 February 2001

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

scientific article published in June 2011

Influence of the Combination of Low-Density Lipoprotein Receptor and Interleukin 28B Genotypes on Lipid Plasma Levels in HIV/Hepatitis C-Coinfected Patients

article

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

article

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients

scientific article published on 29 December 2008

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients

scientific article published in July 2006

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography

scientific article published on August 2013

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.

scientific article published in July 2010

Isolated anti-HBc and hepatitis B virus occult infection.

scientific article published in January 1991

Isolated renal mucormycosis in two AIDS patients

scientific article published on 01 May 1994

KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy

scientific article

LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients.

scientific article published on May 2012

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.

scientific article published on 19 January 2012

Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients.

scientific article published on August 2014

Leishmania infantum (Protozoa, kinetoplastida): transmission from infected patients to experimental animal under conditions that simulate needle-sharing

scientific article published on 01 January 2002

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort

scientific article published on 5 February 2016

Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

article

Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published in August 2009

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published on 9 March 2012

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.

scientific article published in October 2013

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients

scientific article published on 21 December 2016

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

scientific article

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C

article

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients

scientific article published on 7 September 2011

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

scientific article published on 25 January 2007

Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis

scientific article

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

scientific article published on 20 June 2011

Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance

scientific article

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection

scientific article published on 7 December 2015

Low Levels of HIV-1 Plasma Viral Load in Patients Infected with HIV-1 Subtype B and Advanced Immunosuppression

article

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals

scientific article published on 3 February 2017

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir

scientific article published on 23 March 2006

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

article

Low prevalence of occult HBV infection among HIV-infected patients in Southern Spain

scientific article published on 8 November 2011

Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

scientific article

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

scientific article published on 20 March 2015

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.

scientific article published in July 2011

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

scientific article published on 09 November 2006

Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood

scientific article published in December 2001

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

scientific article published in November 2010

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy

scientific article published on 9 November 2002

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses

scientific article published on 7 December 2011

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

scientific article published in October 2009

Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients

scientific article

Necrotizing granulomatous vasculitis in advanced HIV infection

scientific article published on 01 November 2003

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

scientific article

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

scientific article published on 7 June 2012

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

scientific article published on 15 February 2018

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.

scientific article published on 28 March 2013

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

scientific article published on 10 August 2009

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

scientific article published on 23 August 2005

Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.

scientific article published on October 2010

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

scientific article published on 13 December 2011

Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain

scientific article published in March 1989

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

scientific article published in June 2014

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients

scientific article published in October 2010

Prevalence and genotype distribution changes in hepatitis C virus co-infection among human immunodeficiency virus-infected patients

scientific article published on 12 December 2014

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

scientific article published on January 2010

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain

scientific article published in June 1998

Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus- co-infected patients: still a role for liver biopsy?

scientific article published in August 2004

Prevalencia de los marcadores de infección de los virus de las hepatitis en pacientes portadores del VIH en el sur de España

article

Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients

scientific article published on 01 June 1988

Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.

scientific article

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

scientific article published on 7 December 2015

Provirus load changes in untreated and zidovudine-treated human immunodeficiency virus type 1-infected patients.

scientific article published in February 1994

Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine

scientific article published on 01 October 1999

Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.

scientific article

Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment

scientific article

Recombinant EIA for anti-HIV testing is more specific than conventional EIA

scientific article published on 01 January 1988

Regression of Invasive AIDS‐Related Kaposi's Sarcoma Following Antiretroviral Therapy

article

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis

scientific article published in PLoS ONE

Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients

scientific article published in September 2003

Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy

scientific article published in November 2005

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

scientific article published on 08 March 2019

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 5 September 2012

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

scientific article published on 14 August 2013

Rotative agitation RIA. A high sensitivity technique for hepatitis B surface antigen (HBsAg) determinations

scientific article published in January 1986

Rural habitat as risk factor for hepatitis E virus seroconversion in HIV-infected patients: A prospective longitudinal study.

scientific article

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients

scientific article published in April 2009

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes

scientific article published on 12 May 2015

Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C

scientific article published on 10 October 2012

Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine ⬇️

scientific article published on March 5, 1998

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

scientific article published on 27 September 2018

Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1

scientific article published on 01 July 1996

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

scientific article published on 17 December 2013

Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy

article

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

scientific article published on 22 November 2013

Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients.

scientific article published on 28 February 2013

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

scientific article

The changing face of HIV/AIDS in treated patients

scientific article published on July 2009

The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum.

scientific article

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

scientific article published on November 2013

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

scientific article published on 11 September 2007

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy

scientific article published on 12 January 2005

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.

scientific article published on 17 March 2011

Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain

scientific article published on July 1997

Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients

scientific article (publication date: December 2006)

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice

scientific article published on 17 February 2010

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.

scientific article published on November 2013

Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users

scientific article

Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

scientific article published on 27 January 2017

[Conclusions]

scientific article published on 01 July 2013

[Effect of highly active antiretroviral therapy on the clinical onset of AIDS defined by clinical episodes]

scientific article published on 01 May 2002

[Non alcoholic steatosis in HIV infection]

scientific article published on 09 June 2009

Paulina is supported by:

About Paulina

Help